Accumulation of an inactive form of p53 protein in cells treated with TNFα

Cell Death and Differentiation

Volumn 9, Issue 5, 2002, Pages 527-537

  Drane P ^a   Leblanc, V ^a   Miro Mur, F ^a   Saffroy, R ^b   Debuire, B ^b   May, E ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

MCF 7; NF B; p53; p53 activation; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL STRAIN MCF 7; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G1 PHASE; GENE EXPRESSION; HUMANS; NF-KAPPA B; PHOSPHORYLATION; RNA, MESSENGER; SERINE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

MINK CELL FOCUS-FORMING VIRUS;

EID: 85047696134     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400983     Document Type: Article

References (60)

1. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro
2. Tumor necrosis factors: Developments during the last decade
3. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors
4. Effects of Tumor Necrosis Factor-alpha on Antimitogenicity and Cell Cycle-related Proteins in MCF-7 Cells
5. Death receptors: Signaling and modulation
6. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
7. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death
8. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
9. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
10. TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB
11. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
12. Control of apoptosis by Rel/NF-kappaB transcription factors
13. Nuclear factor-kappa B-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug
14. Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-kappaB and Myc/Max
15. Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappa B activity
16. Twenty years of p53 research: Structural and functional aspects of the p53 protein
17. Signaling to p53: Breaking the posttranslational modification code
18. Stabilization and activation of p53 are regulated independently by different phosphorylation events
19. The cellular response to p53: The decision between life and death Oncogene
20. Transcriptional regulation of the p21((WAF1/CIP1)) gene
21. Tissue and cell-specific expression of the p53-target genes: Bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice
22. TNF-alpha induced p21 (waf1) but not bax in colon cancer cells widr with mutated p53: Important role of protein stabilization
23. Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction
24. Prevention of tumor necrosis factor (TNF)-mediated induction of p21WAF1/CIP1 sensitizes MCF-7 carcinoma cells to TNF-induced apoptosis
25. Inhibitors of mammalian G(1) cyclin-dependent kinases
26. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline
27. The HPV-16E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
28. Direct transactivation of c-Ha-Ras gene by p53 - Evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis
29. Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells
30. IkappaB alpha overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-kappaB activation but not tumor necrosis factor-alpha-induced apoptosis
31. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli
32. Tumor necrosis factor alpha and interleukin-1beta regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-beta and NF-kappaB
33. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1 beta
34. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation
35. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53function
36. Expression of the p58 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair
37. Activation of NF-kappaB by antineoplastic agents. Role of protein kinase C
38. Involvement of wild-type p53 in pre-B-cell differentiation in vitro
39. DNA Synthesis-Associated Nuclear Exclusion of p53 in Normal Human Breast Epithelial Cells in Culture
40. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells
41. Regulation and function of the p53 tumor suppressor protein
42. Post-translational modifications and activation of p53 by genotoxic stresses
43. NF-kappaB activation of p53 - A potential mechanism for suppressing cell growth in response to stress
44. Mechanisms of switching on p53: A role for covalent modification?
45. PKR; a sentinel kinase for cellular stress
46. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro
47. Regulation of the specific DNA binding function of p53
48. Activators and target genes of Rel/NF-kappaB transcription factors
49. Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells
50. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers
51. Cytostatic effect of TNFalpha on cancer cells is independent of p21WAF1
52. The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/Waf1 function
53. The Rb/E2F pathway: Expanding roles and emerging paradigms
54. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation
55. p53 and apoptosis
56. p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP
57. Transcriptional repression by the C-terminal domain of p53
58. Reciprocal down-regulation of p53 and SOD2 gene expression - Implication in p53 mediated apoptosis
59. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
60. Real-time quantitation of bcr-abl transcripts in haematological malignancies